TNF and rheumatoid arthritis: Conversely, treatments that reduce inflammation, such as anti-TNF therapy for CD or RA [15] are associated with increased risk of opportunistic infection [16], suggesting that pathways involved in inflammatory diseases are also involved in resistance to infectious diseases.